Department of Neurology, Regional Hospital of Aosta Valley, Aosta, Italy.
BMC Health Serv Res. 2012 Oct 30;12:372. doi: 10.1186/1472-6963-12-372.
Stroke is one of the most relevant reasons of death and disability worldwide. Many cost of illness studies have been performed to evaluate direct and indirect costs of ischaemic stroke, especially within the first year after the acute episode, using different methodologies.
We conducted a longitudinal, retrospective, bottom-up cost of illness study, to evaluate clinical and economic outcomes of a cohort of patients affected by a first cerebrovascular event, including subjects with ischaemic, haemorrhagic or transient episodes. The analysis intended to detect direct costs, within 1, 2 and 3 years from the index event. Clinical patient data collected in regional disease registry were integrated and linked to regional administrative databases to perform the analysis.
The analysis of costs within the first year from the index event included 800 patients. The majority of patients (71.5%) were affected by ischaemic stroke. Overall, per patient costs were €7,079. Overall costs significantly differ according to the type of stroke, with costs for haemorrhagic stroke and ischaemic stroke amounting to €9,044 and €7,289. Hospital costs, including inpatient rehabilitation, were driver of expenditure, accounting for 89.5% of total costs. The multiple regression model showed that sex, level of physical disability and level of neurological deficit predict direct healthcare costs within 1 year. The analysis at 2 and 3 years (per patient costs: €7,901 and €8,874, respectively) showed that majority of costs are concentrated in the first months after the acute event.
This cost analysis highlights the importance to set up significant prevention programs to reduce the economic burden of stroke, which is mostly attributable to hospital and inpatient rehabilitation costs immediately after the acute episode. Although some limitation typical of retrospective analyses the approach of linking clinical and administrative database is a power tool to obtain useful information for healthcare planning.
脑卒中是全球范围内导致死亡和残疾的最重要原因之一。许多疾病经济负担研究已经开展,以评估缺血性脑卒中的直接和间接成本,尤其是在急性发作后 1 年内,使用不同的方法。
我们进行了一项纵向、回顾性、自下而上的疾病经济负担研究,以评估首次脑血管事件患者的临床和经济结局,包括缺血性、出血性或短暂性发作的患者。该分析旨在检测指数事件后 1、2 和 3 年内的直接成本。从区域疾病登记处收集的临床患者数据与区域行政数据库进行整合,以进行分析。
在指数事件后 1 年内的成本分析纳入了 800 名患者。大多数患者(71.5%)患有缺血性脑卒中。总体而言,每位患者的费用为 7079 欧元。总体费用根据卒中类型而显著不同,出血性卒中和缺血性卒中的费用分别为 9044 欧元和 7289 欧元。住院费用,包括住院康复,是支出的驱动因素,占总费用的 89.5%。多回归模型显示,性别、身体残疾程度和神经缺损程度可预测 1 年内的直接医疗保健费用。2 年和 3 年的分析(每位患者的费用分别为 7901 欧元和 8874 欧元)显示,大部分费用集中在急性事件后的头几个月。
本项成本分析强调了制定重大预防计划的重要性,以减轻卒中的经济负担,而卒中的经济负担主要归因于急性发作后立即发生的医院和住院康复费用。尽管存在回顾性分析的一些局限性,但将临床和行政数据库相联系的方法是为医疗保健规划获取有用信息的有力工具。